National Multiple Sclerosis Society

The NMSS has a Chief Executive Officer (CEO) who oversees operations, including financial strategy. As of public record, the CEO is Cyndi Zagieboylo (retired in 2024) succeeded by Dr. Patrick Killian in 2024 (per NMSS press releases). Investment decisions are made by the society's Finance Committee, Board of Trustees, and professional investment advisors, though specific CIO-level names are not publicly disclosed.

The NMSS uses a competitive, peer-reviewed grant process to fund research. It issues requests for proposals (RFPs) in focus areas like progressive MS, repair mechanisms, and clinical trials. The society also partners with academic institutions and pharmaceutical companies through collaborative research agreements (per NMSS research program descriptions).

Neither. The NMSS is a 501(c)(3) nonprofit public charity, not a family office or venture firm. It operates as a membership-based health organization with 50 state chapters. Its endowment and operating assets are managed conservatively to support ongoing programs and research, not to generate profit for private beneficiaries.

The NMSS primarily operates as a grant-making organization, awarding research grants to universities, medical centers, and biotech firms. It does not typically make direct equity investments in companies, though it has sponsored clinical trials and collaborative research consortia that may involve industry partners. For-profit investments are managed separately within its endowment portfolio.

The NMSS is not an investment firm; it focuses on funding research across the spectrum from early discovery to late-stage translational studies, including pilot grants, multi-year research contracts, and clinical trial support. It does not target venture stages, but rather scientific milestones in MS-related research and care.

The NMSS avoids funding outside its mission: it does not invest in for-profit ventures as a primary activity, nor does it fund research unrelated to multiple sclerosis or the central nervous system. Its investment portfolio follows standard nonprofit endowment guidelines, avoiding speculative or high-risk assets to preserve capital for mission programs.

The National Multiple Sclerosis Society is the US member of the Multiple Sclerosis International Federation (MSIF), a global network of MS organizations. NMSS collaborates with MSIF on World MS Day, international research initiatives, and information sharing, but each organization maintains independent governance, funding, and programs.